Decoy Therapeutics: Q3 Earnings Snapshot

HOUSTON (AP) — HOUSTON (AP) — Decoy Therapeutics Inc. (DCOY) on Thursday reported a loss of $3 million in its third quarter. The Houston-based company said it had a loss of $3.53 per share. The biotech drug developer posted revenue of $307,000 in the period. This story was generated by Automated Insights ( http://automatedinsights.com/ap ) using data from Zacks Investment Research. Access a Zacks stock report on DCOY at https://www.zacks.com/ap/DCOY More from this section Associated Press Hegseth and staff reprimanded by guard at Tomb of the Unknown Soldier Nov 11, 2026 Associated Press South Korea US Military 16 hrs ago Associated Press Colombia US Military Nov 11, 2026 Associated Press South Korea US Military 16 hrs ago Inside Killeen Podcast